Our website uses cookies to improve your on-site experience. By using the website, cookies are being used as described in our Policy Document
Warning: To log in you will need to enable cookies and reload the page (Policy Document)
My ePortfolio Register   

ECHELON-2: a large peripheral T-cell lymphoma trial

Please rate this video

Please complete at least one question.

  1. The information in this video was of interest to me Disagree Agree
  2. The information in this video is likely to improve my clinical practice or research Disagree Agree
  3. I would recommend this video to my colleagues Disagree Agree
Thanks for rating
There has been a problem, please refresh and try again.
Published: 02.12.18
Views: 654

Dr Owen O'Connor - Columbia University Medical Centre, New York, USA

Dr Owen O'Connor speaks to ecancer at ASH 2018 about the ECHELON-2 trial.

The ECHELON-2 trail tests brentuximab vedotin and CHP (A CHP) vs CHOP in the frontline treatment of patients with CD30 peripheral T-cell lymphomas.

Dr O'Connor describes the ways this large study was designed and run, and also details the results so far.

Watch his interview about the ACT-1 trial here.

Related videos

follow us

CML Life Banner

Founding partners

European Cancer Organisation European Institute of Oncology

Founding Charities

Foundazione Umberto Veronesi Fondazione IEO Swiss Bridge

Published by

ecancer Global Foundation